Introduction: Currently, there is an increasing number of breast cancer cases detected at an early stage. Removal of the minimum tissue volume that is necessary ensures that the correct shape of the breast is preserved. On the other hand, it is important to maintain negative tissue margins. Aim: The aim is to present our own experience with pre-operative breast tumor marking using the Magseed marker. Material and methods: On the day before surgery, the Magtrace magnetic marker was placed to map the lymph nodes, together with the Magseed magnetic marker placed in the tumor under ultrasound guidance, and the site of the lesion was marked with the skin marker as the surgical site. Before skin incision, the lesion was located using intraoperative ultrasound and the Sentimag probe. After the tumor was cut out, the presence of the marker was confirmed within the specimen using the magnetic method and the compatibility of the ultrasound image before and after the procedure. Results: The study group consisted of 23 patients. Radical surgery was achieved in 20 patients (87%). To assess the sample and tumor sizes, we used the formula for the volume of the ellipsoid published by Angarita et al. We assessed how much of the sample was occupied by the tumor marked with the Magseed marker. We compared the cohorts of 11 patients at the beginning and at the end of the group, showing a significant increase in this parameter. Along with the learning curve, it is possible to more precisely identify the tumor and save healthy breast tissue while improving the aesthetic effect of the breast. Conclusions: The method of localizing non-palpable lesions in the breast using the Magseed marker is simple to use, and its high detection rate directly translates into a reduced rate of non-radical resection during breast-conserving surgery.
Introduction: Following the Russian invasion, more than 3600000 refugees have fled Ukraine and settled down in Poland; this group includes a growing number of breast cancer patients whose treatment had been started in Ukraine and hence required urgent therapy in Poland. Aim: The aim of the study was to analyze the treatment of breast cancer patients from Ukraine, who entered Poland as war refugees – the experience of a single tertiary care institution. Material and methods: The treatment of 25 consecutive breast cancer patients, war refugees from Ukraine was reviewed retrospectively. Results: Patients were treated according to subtype and staging, e.g. surgery, endocrine, anti-HER2 therapy, chemotherapy, radiotherapy. 7 patients received an immediate implant, mesh-based breast reconstruction. In 2 cases, the patients refused breast reconstruction. Conclusions: Nearly 5.5 million refugees across Europe who have fled the combat zones in Ukraine; of these, the vast majority sought shelter in Poland, and many of whom are women. It is expected that breast cancer mortality rates may rise and progress in oncology may slow as the war in Ukraine disrupts routine patient care, clinical trials and research. Hence, support from neighboring countries is mandatory.
Wstęp: W następstwie rosyjskiej inwazji ponad 360 000 uchodźców opuściło Ukrainę i osiedliło się w Polsce. Do tej grupy należy rosnąca liczba pacjentów z rakiem piersi, którzy rozpoczęli leczenie na Ukrainie i w związku z tym wymagali pilnej terapii w Polsce. Cel: Celem pracy była analiza leczenia chorujących na raka piersi pacjentów z Ukrainy, którzy trafili do Polski jako uchodźcy wojenni, w pojedynczym ośrodku referencyjnym. Materiał i metody: Dokonano retrospektywnej analizy leczenia u 25 kolejnych pacjentów z rakiem piersi, uchodźców wojennych z Ukrainy. Wyniki: Pacjenci byli leczeni zgodnie z podtypem oraz stopniem zaawansowania klinicznego nowotworu m.in. chirurgicznie, terapią celowaną anty-HER2, chemioterapią oraz radioterapią. Siedmiu pacjentów zostało poddanych jednoczasowej rekonstrukcji piersi z użyciem implantu i siatki. Dwóch pacjentów odmówiło rekonstrukcji piersi. Wnioski: Niemal 5,5 miliona uchodźców w całej Europie opuściło strefy walki w Ukrainie. Zdecydowana większość z nich szukała schronienia w Polsce, a wiele z nich to kobiety. Oczekuje się, że śmiertelność z powodu raka piersi może wzrosnąć, a postęp w onkologii może uleć spowolnieniu, ponieważ wojna w Ukrainie zakłóca rutynową opiekę nad pacjentem, pracę naukową i badania kliniczne. Dlatego wsparcie krajów sąsiedzkich jest obowiązkowe.
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.